The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Tue., Sep. 17, 8:28 AM

Slide #7. Pluristem Therapeutics Inc. (NASDAQ:PSTI) 1 for 10 Reverse Split

Announced: 7/24/2019
Stock Split: 1 for 10
Record Date: 7/24/2019
Pay Date: 7/25/2019
PSTI Optionable?: Yes

Pluristem Therapeutics is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Co.'s product candidates include: PLX-PAD, which is in a multinational clinical trial in critical limb ischemia, and in a multinational clinical trial in recovery following surgery for hip fracture; PLX-R18, which is under development in the United States for acute radiation syndrome, as well as in a trial in the United States and Israel for incomplete hematopoietic recovery following hematopoietic cell transplantation; and PLX-Immune, which is under pre-clinical development for treatment of certain types of human cancer.
PSTI Detailed Information Page & Split History »

Company Name: 
Pluristem Therapeutics Inc
Website: 
www.pluristem.com
Sector: 
Biotechnology
Number of ETFs Holding PSTI: 
1
Total Market Value Held by ETFs: 
$20433
Total Market Capitalization: 
$64.00M
% of Market Cap. Held by ETFs: 
0.03%

Open the PSTI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
84th percentile
(ranked higher than approx. 84% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.